Hu Yu-Yuan, Cheng Xin-Meng, Wu Nan, Tao Yang, Wang Xue-Ning
Division of Cardiovascular Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Front Cardiovasc Med. 2022 Apr 15;9:890607. doi: 10.3389/fcvm.2022.890607. eCollection 2022.
Aortic dissection (AD) is a fatal cardiovascular disease. It is caused by a rupture of the aortic intima or bleeding of the aortic wall that leads to the separation of different aortic wall layers. Patients with untreated AD have a mortality rate of 1-2% per hour after symptom onset. Therefore, effective biomarkers and therapeutic targets are needed to reduce AD-associated mortality. With the development of molecular technology, researchers have begun to explore the pathogenesis of AD at gene and protein levels, and have made some progress, but the pathogenesis of AD remains unclear. Non-coding RNAs, such as microRNAs, lncRNAs, and circRNAs, have been identified as basic regulators of gene expression and are found to play a key role in the pathogenesis of AD. Thus, providing a theoretical basis for developing these non-coding RNAs as clinical biomarkers and new therapeutic targets for AD in the future. Previous studies on the pathogenesis of AD focused on miRNAs, but recently, there have been an increasing number of studies that explore the role of lncRNAs, and circRNAs in AD. This review summarizes the existing knowledge on the roles of various non-coding RNAs in the pathogenesis of AD, discusses their potential role as clinical biomarkers and therapeutic targets, states the limitations of existing evidence, and recommends future avenues of research on the pathogenesis of AD.
主动脉夹层(AD)是一种致命的心血管疾病。它由主动脉内膜破裂或主动脉壁出血引起,导致主动脉壁各层分离。未经治疗的AD患者在症状出现后每小时的死亡率为1%-2%。因此,需要有效的生物标志物和治疗靶点来降低与AD相关的死亡率。随着分子技术的发展,研究人员已开始在基因和蛋白质水平探索AD的发病机制,并取得了一些进展,但AD的发病机制仍不清楚。非编码RNA,如微小RNA(miRNA)、长链非编码RNA(lncRNA)和环状RNA(circRNA),已被确定为基因表达的基本调节因子,并被发现在AD的发病机制中起关键作用。因此,为将来将这些非编码RNA开发为AD的临床生物标志物和新的治疗靶点提供了理论基础。以往关于AD发病机制的研究主要集中在miRNA上,但最近,越来越多的研究开始探索lncRNA和circRNA在AD中的作用。本综述总结了各种非编码RNA在AD发病机制中的作用的现有知识,讨论了它们作为临床生物标志物和治疗靶点的潜在作用,阐述了现有证据的局限性,并推荐了未来AD发病机制的研究方向。